The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Eyzeetan 0.3 mg/ml + 5 mg/ml eye drops, solution



Morningside Healthcare (Malta) LimitedPA23142/013/001

Main Information

Trade NameEyzeetan 0.3 mg/ml + 5 mg/ml eye drops, solution
Active SubstancesBimatoprost
Timolol Maleate
Dosage FormEye drops, solution
Licence HolderMorningside Healthcare (Malta) Limited
Licence NumberPA23142/013/001

Group Information

ATC CodeS01ED51 timolol, combinations

Status

License statusAuthorised
Licence Issued01/11/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back